drugset / Trial / NCT04928495
Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
Phase 3
Unknown
219 enrolled
Federal University of Ceará
Ceará Health Secretariat - SESA · collabCentral Laboratory of Public Health of Ceará - Lacen-CE · collabHealth Surveillance Secretariat - SVS · collabLeonardo da Vinci Hospital - HLV · collabMunicipal Health Secretary - SMS-Fortaleza · collabPaulista School of Medicine-EPM, UNIFESP · collabSão José Hospital for Infectious Diseases - HSJ · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Clinical, control, double-blind, randomized experimentation with N-acetylcysteine and bromhexine for COVID-19.
Timeline
- Start
- 2021-07-15
- Primary completion
- 2022-04-09
- Completion
- 2022-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bromhexine | Small molecule | 32 mg | — |
| Comparator | N-acetylcysteine | Small molecule | 1800 mg | — |